Newsletter | November 20, 2024

11.20.24 -- Tips For Addressing Vaccine Demand – Strategies For C&G And mRNA

Getting Your Investigational Drug Regulatory Ready

Navigating regulatory requirements can be overwhelming and time-consuming. Explore some basic information to help you approach regulatory policies as well as helpful strategies to facilitate efficient regulatory review and drug approval.

 

Tips For Viral Vector Production

Gain insight into the challenges of viral vector manufacturing, and learn how meticulous purification optimization can maximize recovery and impurity removal by leveraging scalable downstream technologies to meet regulatory and process economy requirements.

 

Strategies For Scaling Up mRNA Manufacturing To Address Vaccine Demand

Katarina Stenklo delves into how flexible approaches can help address the considerations and hurdles in mRNA manufacturing, including managing mRNA size, structure, and stability, adapting workflows from other modalities, and considerations for scale up.

 

Bringing Allogeneic Cell Therapy To Patient Care

Bringing allogeneic cell therapy to patient care will require collaborative innovation in drug development and production. Discover why flexible, closed, and automated solutions are necessary to support the treatment options and increasing scale of the industry.